Research ArticleFeatured Articles
Multifactorial Approach to the Primary and Secondary Prevention of Atherosclerosis
Carl J. Lavie and Richard V. Milani
Ochsner Journal December 2003, 5 (1) 12-17;
Carl J. Lavie
Ochsner Heart & Vascular Institute, Department of Cardiology, Ochsner Clinic Foundation, New Orleans, LA
MDRichard V. Milani
Ochsner Heart & Vascular Institute, Department of Cardiology, Ochsner Clinic Foundation, New Orleans, LA
MD
REFERENCES
- ↵
- Milani R. V.,
- Lavie C. J.,
- Gilliland Y. E.
- ↵
- Smith S. C. Jr.,
- Greenland P.,
- Grundy S. M.
- National Heart, Lung, and Blood Institute
- ↵
- Milani R. V.,
- Lavie C. J.
- ↵
- U.S. Department of Health and Human Services
- ↵
- American Heart Association
- Carretero O. A.,
- Oparil S.
- National Heart, Lung, and Blood Institute
- ↵
- Lavie C. J.,
- Ventura H. O.,
- Messerli F. H.
- ↵
- Lavie C. J.,
- Milani R. V.,
- Mehra M. R.
- ↵
- Yusuf S.,
- Sleight P.,
- Pogue J.
- ↵
- O'Keefe J. H.,
- Wetzel M.,
- Moe R. R.,
- Bronsnahan K.,
- Lavie C. J.
- ↵
- Lindholm L. H.,
- Ibsen H.,
- Dahlof B.
- ↵
- Lavie C. J.,
- Gau G. T.,
- Squires R. W.
- Lavie C. J.,
- Milani R. V.
- Lavie C. J.,
- Milani R. V.
- ↵
- Ross S. D.,
- Allen I. E.,
- Connelly J. E.
- ↵
- Byington R. P.,
- Davis B. R.,
- Plehn J. F.
- ↵
- Waters D.,
- Schwartz G. G.,
- Olsson A. G.
- ↵(2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:7–22, pmid:12114036.
- ↵
- American Diabetes Association: clinical practice recommendations 1997
- ↵
- Davis P. H.,
- Dambrosia J. M.,
- Schoenberg B. S.
- ↵(2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486–2497, pmid:11368702.
- ↵
- Milani R. V.,
- Lavie C. J.
- ↵
- Lavie C. J.,
- Milani R.,
- Mehra M. R.
- Lavie C. J.,
- Milani R. V.,
- Messerli F. H.
- Lavie C. J.,
- Milani R. V.,
- Messerli F. H.
- ↵
- Lavie C. J.,
- Milani R. V.
- ↵
- Lavie C. J.,
- Milani R. V.,
- Morchedi A.
- ↵
- Mokdad A. H.,
- Serdula M. K.,
- Dietz W. H.
- ↵
- Williamson D. F.,
- Pamuk E.,
- Thun M.
- ↵
- Lavie C. J.,
- Milani R. V.,
- Marks P.
- ↵
- Ridker P. M.,
- Rifai N.,
- Rose L.
- ↵
- Ali A.,
- Mehra M. R.,
- Lavie C. J.
- ↵
- Lavie C. J.,
- Milani R. V.,
- O'Keefe J. H.
- ↵(2002) Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288:2015–2022, pmid:12387654.
- ↵
- Danesh J.,
- Collins R.,
- Peto R.
- ↵
- Lavie C. J.,
- Milani R. V.
- ↵
- Grady D.,
- Herrington D.,
- Bittner V.
- ↵
- Pradhan A. D.,
- Manson J. E.,
- Rossouw J. E.
- ↵
- Lavie C. J.,
- Mailander L.,
- Milani R. V.
- ↵
- Milani R. V.,
- Lavie C. J.,
- Cassidy M. M.
- Lavie C. J.,
- Milani R. V.
- Lavie C. J.,
- Milani R. V.
- Lavie C. J.,
- Milani R. V.,
- DeGruiter H.
- ↵
- Straus S. E.,
- Majumdar S. R.,
- McAlister F. A.
- ↵
- Lavie C. J.,
- Genton E.
- ↵
- Weisman S. M.,
- Graham D. Y.
- ↵(1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 348:1329–1339, pmid:8918275.
- ↵
- Yusuf S.,
- Zhao F.,
- Mehta S. R.
- ↵
- Gaspoz J. M.,
- Coxson P. G.,
- Goldman P. A.
- ↵
- Lavie C. J.,
- Squires R. W.,
- Gau G. T.
- ↵
- Lavie C. J.,
- Milani R. V.
- ↵
- Alaswad K.,
- Lavie C. J.,
- Milani R. V.
- ↵
- He K.,
- Rimm E. B.,
- Merchant A.
- ↵
- Milani R. V.,
- Lavie C. J.,
- Brewer G.,
- Mehra M. R.
- ↵
- Lavie C. J.,
- Milani R. V.,
- Cassidy M. M.
- ↵
- ↵
- Lucini D.,
- Milani R. V.,
- Costantino G.
In this issue
Multifactorial Approach to the Primary and Secondary Prevention of Atherosclerosis
Carl J. Lavie, Richard V. Milani
Ochsner Journal Dec 2003, 5 (1) 12-17;